CEFIXIME - SPECTRUM OF ANTIBACTERIAL ACTIVITY AGAINST 16016 CLINICAL ISOLATES

被引：38

作者：

BARRY, AL

JONES, RN

机构：

来源：

PEDIATRIC INFECTIOUS DISEASE JOURNAL | 1987年 / 6卷 / 10期

关键词：

D O I：

10.1097/00006454-198710000-00033

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：954 / 957

页数：4

共 13 条

[1] PENETRATION OF CEFIXIME INTO FIBRIN CLOTS AND INVIVO EFFICACY AGAINST ESCHERICHIA-COLI, KLEBSIELLA-PNEUMONIAE, AND STAPHYLOCOCCUS-AUREUS [J].

BERGERON, MG ;

TURCOTTE, A .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (06) :913-916

[2] INVITRO ACTIVITY OF DIFLOXACIN HYDROCHLORIDE (A-56619), A-56620, AND CEFIXIME (CL 284,635-FK 027) AGAINST SELECTED GENITAL PATHOGENS [J].

BOWIE, WR ;

SHAW, CE ;

CHAN, DGW ;

BOYD, J ;

BLACK, WA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (04) :590-593

[3] THE PHARMACOKINETIC AND BACTERICIDAL CHARACTERISTICS OF ORAL CEFIXIME [J].

BRITTAIN, DC ;

SCULLY, BE ;

HIROSE, T ;

NEU, HC .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (05) :590-594

[4] CEFIXIME DISK SUSCEPTIBILITY TEST CRITERIA [J].

FUCHS, PC ;

BARRY, AL ;

JONES, RN .

JOURNAL OF CLINICAL MICROBIOLOGY, 1986, 24 (04) :647-649

[5] INVITRO EVALUATION OF CEFIXIME (FK027, FR17027, CL284635) - SPECTRUM AGAINST RECENT CLINICAL ISOLATES, COMPARATIVE ANTIMICROBIAL ACTIVITY, BETA-LACTAMASE STABILITY, AND PRELIMINARY SUSCEPTIBILITY TESTING CRITERIA [J].

FUCHS, PC ;

JONES, RN ;

BARRY, AL ;

THORNSBERRY, C ;

AYERS, LW ;

GAVAN, TL ;

GERLACH, EH .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1986, 5 (02) :151-162

[6] PHARMACOKINETICS OF CEFIXIME (CL-284,635, FK-027) IN HEALTHY-SUBJECTS AND PATIENTS WITH RENAL-INSUFFICIENCY [J].

GUAY, DRP ;

MEATHERALL, RC ;

HARDING, GK ;

BROWN, GR .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (03) :485-490

[7] ANTIMICROBIAL ACTIVITY OF RO-19-5247 (T-2525), A NEW ORAL CEPHALOSPORIN, TESTED AGAINST 7,745 RECENT CLINICAL ISOLATES [J].

JONES, RN ;

FUCHS, PC ;

BARRY, AL ;

AYERS, LW ;

GERLACH, EH ;

GAVAN, TL .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1987, 6 (03) :193-198

[8] INVITRO AND INVIVO ANTIBACTERIAL PROPERTIES OF FK-027, A NEW ORALLY ACTIVE CEPHEM ANTIBIOTIC [J].

KAMIMURA, T ;

KOJO, H ;

MATSUMOTO, Y ;

MINE, Y ;

GOTO, S ;

KUWAHARA, S .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (01) :98-104

[9] COMPARATIVE INVITRO ACTIVITY AND BETA-LACTAMASE STABILITY OF FR-17027, A NEW ORALLY ACTIVE CEPHALOSPORIN [J].

NEU, HC ;

CHIN, NX ;

LABTHAVIKUL, P .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (02) :174-180

[10] INVITRO ACTIVITIES OF SELECTED NEW AND LONG-ACTING CEPHALOSPORINS AGAINST PASTEURELLA-MULTOCIDA [J].

NOEL, GJ ;

TEELE, DW .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (02) :344-345

← 1 2 →